S-Space

Browse

Publisher

Showing results 1 to 4 of 4

Issue Date	Title / Author(s) / Citation	File
2013-03	Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: the OOTR-N001 study Chow, Louis W. C.; Tung, Stewart Y.; Ng, Ting-Ying; Im, Seock-Ah; Lee, Min-Hyuk; Yip, Adrian Y. S.; Toi, Masakazu; Glueck, Stefan Expert Opinion on Investigational Drugs, Vol.22 No.3, pp.299-307	DOI
2016-02	Pertuzumab in gastrointestinal cancer Oh, Do-Youn; Bang, Yung-Jue Expert Opinion on Biological Therapy, Vol.16 No.2, pp.243-253	DOI
2022-07	A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer Cho, Byoung Chul; Goldberg, Sarah B.; Kim, Dong-Wan; Socinski, Mark A.; Burns, Timothy F.; Lwin, Zarnie; Pathan, Nuzhat; Ma, Wei Dong; Masters, Joanna C.; Cossons, Nandini; Wilner, Keith; Nishio, Makoto; Husain, Hatim Expert Opinion on Investigational Drugs, Vol.31 No.7, pp.747-757
2022-11	Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension Chang, Sung-A; Lee, Sang Hyun; Choi, Jung Hyun; Chung, Wook-Jin; Choi, Jae Young; Kim, Hyung-Kwan; Jung, Hae-Ok; Park, Seong-Mi; Kim, Won-Jang; Jung, Su Young; Chang, Hyuk-Jae Expert Opinion on Drug Safety, Vol.21 No.11, pp.1423-1432	DOI